Sherwin-Williams (NYSE:SHW) Price Target Cut to $355.00 by Analysts at Barclays

Sherwin-Williams (NYSE:SHW) had its price objective decreased by analysts at Barclays from $385.00 to $355.00 in a research report issued on Tuesday,Benzinga reports. The firm presently has an “equal weight” rating on the specialty chemicals company’s stock. Barclays‘s price target would suggest a potential upside of 2.02% from the stock’s current price.

Several other research firms have also recently issued reports on SHW. Robert W. Baird set a $370.00 price target on shares of Sherwin-Williams in a report on Friday, January 31st. Citigroup restated a “buy” rating and set a $423.00 price objective (up previously from $418.00) on shares of Sherwin-Williams in a report on Wednesday, February 26th. Morgan Stanley lowered their target price on shares of Sherwin-Williams from $450.00 to $405.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. Zelman & Associates upgraded shares of Sherwin-Williams to a “strong-buy” rating in a research note on Friday, January 17th. Finally, Jefferies Financial Group restated a “hold” rating and issued a $380.00 target price (down from $423.00) on shares of Sherwin-Williams in a research note on Monday, March 10th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating, ten have issued a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $400.19.

Sherwin-Williams Stock Down 0.4 %

Shares of SHW traded down $1.24 during mid-day trading on Tuesday, hitting $347.96. 230,169 shares of the company’s stock were exchanged, compared to its average volume of 1,725,198. The company has a market cap of $87.51 billion, a price-to-earnings ratio of 32.92, a P/E/G ratio of 2.98 and a beta of 1.23. The stock’s 50-day moving average is $353.50 and its 200-day moving average is $363.63. Sherwin-Williams has a fifty-two week low of $282.09 and a fifty-two week high of $400.42. The company has a debt-to-equity ratio of 2.02, a quick ratio of 0.46 and a current ratio of 0.79.

Sherwin-Williams (NYSE:SHW) last issued its quarterly earnings data on Thursday, January 30th. The specialty chemicals company reported $2.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.07 by $0.02. Sherwin-Williams had a return on equity of 74.50% and a net margin of 11.61%. During the same quarter last year, the business earned $1.81 EPS. On average, sell-side analysts anticipate that Sherwin-Williams will post 12 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Sherwin-Williams news, insider Colin M. Davie sold 2,799 shares of the business’s stock in a transaction dated Thursday, February 27th. The stock was sold at an average price of $360.30, for a total transaction of $1,008,479.70. Following the sale, the insider now owns 5,365 shares in the company, valued at approximately $1,933,009.50. The trade was a 34.28 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.60% of the stock is owned by insiders.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in SHW. Norges Bank acquired a new stake in shares of Sherwin-Williams during the 4th quarter valued at $1,359,747,000. Capital Research Global Investors lifted its position in shares of Sherwin-Williams by 47.1% during the 4th quarter. Capital Research Global Investors now owns 2,998,647 shares of the specialty chemicals company’s stock worth $1,019,329,000 after buying an additional 960,724 shares during the period. Barclays PLC lifted its holdings in shares of Sherwin-Williams by 54.2% during the fourth quarter. Barclays PLC now owns 2,073,533 shares of the specialty chemicals company’s stock valued at $704,855,000 after acquiring an additional 728,798 shares during the period. Raymond James Financial Inc. bought a new position in Sherwin-Williams in the 4th quarter worth approximately $230,829,000. Finally, Northern Trust Corp increased its stake in shares of Sherwin-Williams by 28.0% in the 4th quarter. Northern Trust Corp now owns 2,725,827 shares of the specialty chemicals company’s stock valued at $926,590,000 after buying an additional 595,586 shares during the period. 77.67% of the stock is owned by hedge funds and other institutional investors.

Sherwin-Williams Company Profile

The Sherwin-Williams Company engages in the development, manufacture, distribution, and sale of paints, coating, and related products to professional, industrial, commercial, and retail customers. It operates through three segments: Paint Stores Group, Consumer Brands Group, and Performance Coatings Group.